MetaCap

SeaStar Medical (ICU) vs Picard Medical (PMI)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

SeaStar Medical (ICU) has outperformed Picard Medical (PMI) over the past year, losing 47.0% versus a loss of 98.0%. Picard Medical is the larger company by market cap ($22.6 million vs $18.4 million), about 1.2 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ICU-47.04%PMI-97.98%
+44%-31%-106%
Oct 8, 20251 yearOct 8, 2026
ICU-61.90%PMI-95.78%
+123%+7%-109%
Aug 25, 20255 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ICU versus PMI key metrics
MetricICUPMI
Share price$3.49$9.68
Market cap$18.36M$22.64M
1-day change-6.18%+3.31%
YTD return+45.42%-88.94%
1-year return-47.04%-97.98%
5-year return-99.86%—
EPS (TTM)$-2.97$-6.93
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$7.35$684.00
52-week low$2.07$2.65
Distance from 52-week high-52.52%-98.58%
Analyst consensusnone—
Avg. price target upside+186.53%—
Average volume99.80K1.69M
Shares outstanding5.26M2.34M
Employees1875
SectorHealthcareHealthcare
IndustryBiotechnologyMedical Devices

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • ICU has outperformed PMI by 50.9 percentage points over the past year.

About SeaStar Medical

ICU stock →

SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis.

Healthcare · Biotechnology · 18 employees

About Picard Medical

PMI stock →

Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure.

Healthcare · Medical Devices · 75 employees

ICU vs PMI FAQ

Which is bigger, SeaStar Medical or Picard Medical?

Picard Medical (PMI) is larger, with a market capitalization of $22.64M compared with $18.36M for SeaStar Medical (ICU).

Which stock has performed better over the past year, ICU or PMI?

ICU returned -47.04% over the past 12 months, compared with -97.98% for PMI (price return, excluding dividends). Past performance does not predict future results.

Are SeaStar Medical and Picard Medical in the same industry?

Both are in the Healthcare sector, but in different industries: Biotechnology for SeaStar Medical and Medical Devices for Picard Medical.

More comparisons